Premium
Punto de vista: Neurocisticercosis: ¿Es útil la serología en ausencia de imágenes cerebrales?
Author(s) -
Garcia Hector H.,
Rodriguez Silvia,
Gilman Robert H.,
Gonzalez Armando E.,
Tsang Victor C. W.
Publication year - 2012
Publication title -
tropical medicine and international health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.056
H-Index - 114
eISSN - 1365-3156
pISSN - 1360-2276
DOI - 10.1111/j.1365-3156.2012.03037.x
Subject(s) - neurocysticercosis , serology , cysticercosis , asymptomatic , etiology , neuroimaging , medicine , disease , population , taenia solium , pathology , immunology , environmental health , antibody , psychiatry
Neurocysticercosis (NCC) is endemic in most parts of the world and is now recognised as an important contributor to neurological disease. Serological diagnosis of NCC improved greatly in the past two decades and contributed to demonstrating previously unsuspected regions of endemicity. Claims for an accurate serological screening tool for human cysticercosis are frequently raised. However, after symptomatic therapeutics are applied, management of NCC is driven by the characteristics of the central nervous system infection in terms of viability, number, location size and evolutionary stage of parasites, as well as by the resulting inflammation. It is unclear whether, in the absence of neuroimaging, serological confirmation of aetiology of suspected cases (neurologically symptomatic) or detection of asymptomatic cases in population screening would affect their management or prognosis.